Schedule 13G ownership disclosure
MEREO BIOPHARMA GROUP PLC
Security class unavailable · CUSIP: 589492107
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,610,000
- Percent of class
- 9.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-22-000343
- Form type
- SC 13G
- Filer
- Mereo BioPharma Group plc
- CIK
- CIK 1719714
- Filed
- Feb 14, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership